Full Schedule

5:30 AM – 6:15 AM MST

Guided Yoga

Location: Sheraton Hotel- Phoenix Ballroom DE

7:00 AM – 7:30 AM MST

30 Minute Guided Meditation

Location: 230 North

7:00 AM – 8:30 AM MST

Breakfast

7:00 AM – 5:00 PM MST

Meditation/Quiet Room

Location: 230 North

7:15 AM – 9:00 AM MST

CFF EnVision Mentees Meeting (working breakfast)

Location: Sheraton Hotel- Ahwatukee

Affiliate Meeting

7:15 AM – 9:15 AM MST

AF-- Adult Fellows Session

Location: 106 A-C (West)

Chair: – University of North Carolina at Chapel Hill

Chair: – University of Pittsburgh

Facilitator: – University of Pittsburgh Medical Center

CLIN

7:15 AM – 9:15 AM MST

AF1- Obesity Management in Cystic Fibrosis: A Case of Semaglutide Use

Location: 106 A-C (West)

Speaker: – Brown University/Lifespan

7:15 AM – 9:15 AM MST

AF2- Cystic fibrosis related bone disease in an adult treated with sequential osteoporosis therapy: anabolic followed by anti-resorptive therapy

Location: 106 A-C (West)

Speaker: – Emory University School of Medicine

7:15 AM – 9:15 AM MST

AF3- CYPly the best: Hepatic enzyme genotyping to tailor mental health treatment and more in cystic fibrosis

Location: 106 A-C (West)

Speaker: – University of North Carolina at Chapel Hill

7:15 AM – 9:15 AM MST

AF4- Reintroduction of CFTR modulator therapy following hepatocyte necrosis secondary to elexacaftor/tezacaftor/ivacaftor

Location: 106 A-C (West)

Speaker: – Manchester Adult Cystic Fibrosis Centre

7:15 AM – 9:15 AM MST

AF5- Mediastinitis in a Patient with Cystic Fibrosis

Location: 106 A-C (West)

Speaker: – UCSF

7:15 AM – 9:15 AM MST

AF6- Successful home-based desensitization of ETI in a patient with previous intolerance due to severe rash

Location: 106 A-C (West)

Speaker: – Oregon Health and Science University

7:15 AM – 9:15 AM MST

AF7- Pregnancy in Cystic Fibrosis with Advanced Lung Disease

Location: 106 A-C (West)

Speaker: – Medical University of South Carolina

7:15 AM – 9:15 AM MST

PF--Pediatric Fellows Session

Location: 101 A-C (West)

Chair: – University of Toronto, Hospital for Sick Children

Chair: – Yale University School of Medicine

Facilitator: – Seattle Children's Hospital/University of Washington

CLIN

7:15 AM – 9:15 AM MST

PF1- A case of severe scoliosis due to neuromuscular disease in a patient with cystic fibrosis

Location: 101 A-C (West)

Speaker: – Children's Hospital of Philadelphia

7:15 AM – 9:15 AM MST

PF2- Double trouble: Two pulmonary abscesses of uncertain etiology in a 12 year-old boy

Location: 101 A-C (West)

Speaker: – The Hospital for Sick Children

7:15 AM – 9:15 AM MST

PF3- Acute Respiratory Failure in a patient with Cystic Fibrosis secondary to Coccidiomycosis (Valley Fever)

Location: 101 A-C (West)

Speaker: – Nationwide Childrens Hospital

7:15 AM – 9:15 AM MST

PF4- You Can’t Always Blame Mucus

Location: 101 A-C (West)

Speaker: – BC Children's Hospital, Vancouver

7:15 AM – 9:15 AM MST

PF5- Clogged pipes: GI dysfunction in a teenager with cystic fibrosis on CFTR modulatortherapy

Location: 101 A-C (West)

Speaker: – Emory University

7:15 AM – 9:15 AM MST

PF6- “Short Gut in a Toddler with Cystic Fibrosis – A Nutritional Dilemma”

Location: 101 A-C (West)

Speaker: – Children's National Hospital

7:15 AM – 9:15 AM MST

PF7- Failure of response to ELX-TEZ-IVA. Altered Pharmacokinetics or non-compliance due to Munchausen by proxy?

Location: 101 A-C (West)

Speaker: – New York Presbyterian Hospital ( Columbia University Medical Center )

7:15 AM – 9:15 AM MST

W16--Pathogenesis of Infection

Location: 105 C (West)

Chair: – The Hospital for Sick Children

Chair: – University of Texas Health Science Center at Tyler

IMI

7:15 AM – 9:15 AM MST

W16.1- Bronchoscopy sampling finds that intra-lung bacterial migration contributes to persistent Pseudomonas aeruginosa infection after ETI

Location: 105 C (West)

Speaker: – University of Washington

7:15 AM – 9:15 AM MST

W16.2- Airway infection with Pseudomonas harboring filamentous phage at high levels is associated with lung function decline in longitudinal cystic fibrosis cohort

Location: 105 C (West)

Speaker: – Children's Hospital of Los Angeles / University of Southern California

7:15 AM – 9:15 AM MST

W16.3- Host-pathogen interactions in a cystic fibrosis polymicrobial infection model

Location: 105 C (West)

Speaker: – Geisel School of Medicine at Dartmouth College

7:15 AM – 9:15 AM MST

W16.4- CFTR Modulators Increase Viral Mobility in Healthy and CF Airway Epithelial Cells

Location: 105 C (West)

Speaker: – The University of North Carolina at Chapel Hill School of Medicine

7:15 AM – 9:15 AM MST

W16.5- Intestinal Bacteroides modulate systemic inflammation and the microbial ecology in a mouse model of CF: Evidence for propionate reducing inflammatory cytokines and impacting colonization

Location: 105 C (West)

Speaker: – Dartmouth College

7:15 AM – 9:15 AM MST

W17--Cell Biology of the Airway Epithelium

Location: 103 AB (West)

Chair: – University of Colorado

Chair: – The Ohio State University

APPTT

7:15 AM – 9:15 AM MST

W17.1- Influence of post-natal lung development and host microbiota on the neonatal airway mucus clearance system

Location: 103 AB (West)

Speaker: – University of North Carolina at Chapel Hill Marsico Lung Institute

7:15 AM – 9:15 AM MST

W17.2- SCGB3A2-positive Distal Airway Secretory Cells Are a Therapeutic Target for CFTR Function Restoration

Location: 103 AB (West)

Speaker: – UNC Chapel Hill

7:15 AM – 9:15 AM MST

W17.3- Sinonasal epithelial responses to long-term highly effective CFTR modulator therapy

Location: 103 AB (West)

Speaker: – University of Colorado

7:15 AM – 9:15 AM MST

W17.4- Single-cell functional profiling of CFTR in primary and iPSC-derived CF-relevant epithelia

Location: 103 AB (West)

Speaker: – Cedar-Sinai Medica Center

7:15 AM – 9:15 AM MST

W17.5- Airway submucosal gland cell biology, physiology, and pathophysiology in cystic fibrosis

Location: 103 AB (West)

Speaker: – The University of Iowa

7:15 AM – 9:15 AM MST

DG12--Mission Possible: Overcoming Pharmacotherapy Obstacles

Location: 225 AB (North)

Chair: – University of Kentucky College of Pharmacy

Chair: – Yale New Haven Health System

Speaker: – University of Kentucky HealthCare - Kentucky Children's Hospital

Speaker: – Pediatric Pulmonology

Speaker: – The Children's Hospital of the King's Daughters

Speaker: – Mayo Clinic

PHARM

7:15 AM – 9:15 AM MST

DG13--Exercise & Body Composition

Location: 124 AB (North)

Chair: – University of Kansas Health System

Chair: – Johns Hopkins Hospital

Speaker: – Prisma Health Midlands

Speaker: – JW Ruby Memorial Hospital, WVU Medicine

Speaker: – Billings Clinic

Speaker: – Billings Clinic CF Center

Speaker: – Adult Cystic Fibrosis Center of Central Texas

Speaker: – St. Luke's Cystic Fibrosis Center of Idaho

Speaker: – Boston Children's Health Physicians

NTRPT/RT

7:15 AM – 9:15 AM MST

DG14--Seeing More Than CF: Care Team & Caregiver Perspectives on Dealing with CF Coupled with Another Complex Disease?

Location: 229 AB (North)

Chair: – Children's Hospital of Alabama

Chair: – Nemours Children's Hospital~Delaware

Speaker: – Nemours Children's Hospital Delaware

Community Speaker: – UAB

Speaker: – UAB Division of Pediatrics

Speaker: – Augusta University Children's Hospital of Georgia

PT/RT

7:15 AM – 9:15 AM MST

DG15--Pulmonary Function Tests (PFT) Interpretation 101: What is in the Numbers?

Location: 224 AB (North)

Chair: – Jefferson Adult CF Center

Chair: – University Hospitals Rainbow Babies and Children's

Speaker: – IU Health

Speaker: – Rainbow Babies and Children's

Speaker: – Dell Children's Medical Center of Central Texas

Speaker: – Primary Children's CF Center

Speaker: – Primary Children's Hospital CF Center

NRS

7:15 AM – 9:15 AM MST

DG16--Research Coordinator Updates & Special Case Presentations

Location: 121 A-C (North)

Chair: – UPMC Children's Hospital of Pittsburgh

Chair: – Cystic Fibrosis Foundation

Speaker: – UPMC Children's Hospital of Pittsburgh

Speaker: – Cystic Fibrosis Foundation

Speaker: – Seattle Children's

Speaker: – Children's Mercy

Speaker: – TDN Coordinating Center

CLIN

7:15 AM – 9:15 AM MST

DG17--Bringing Health Equity Into the CF Clinic

Location: 126 A-C (North)

Chair: – University of Kansas Health System

Chair: – University of California, San Francisco

Speaker: – Northwestern University Feinberg School of Medicine

Community Speaker: – University of Kansas CF Clinic

Speaker: – UCSF Benioff Children's Hospital

Speaker: – Columbia University

Speaker: – Columbia University Irving Medical Center

Speaker: – Cystic Fibrosis Center- AUMC, CHOG

Community Speaker: – CA Dept of Education

Community Speaker:

HEAC

7:15 AM – 9:15 AM MST

DG18--APP Tips & Tricks for Telemedicine

Location: 228 AB (North)

Chair: – University of Mississippi Medical Center

Chair: – University of North Carolina at Chapel Hill

Speaker: – UC San Diego Health

Speaker: – Cystic Fibrosis Clinic at Santa Barbara Cottage Hospital

Speaker: – Cystic Fibrosis Foundation

Speaker: – University of Cincinnati

NRS

7:15 AM – 9:15 AM MST

DG19--What are We Doing Right? Positive Development, Resiliency, & Wellbeing

Location: 129 AB (North)

Chair: – Augusta University

Chair: – Children's National Hospital

Speaker: – Cystic Fibrosis Foundation

Speaker: – Seattle Children's Hospital

Speaker: – Primary Children's CF Center, University of Utah School of Medicine

Community Speaker: – Happy Heart Families

Community Speaker:

SW/PSYCH

8:00 AM – 5:00 PM MST

Patient Registry Classroom

Location: Convention Center-223 (North)

Affiliate Meeting

8:00 AM – 5:30 PM MST

Exhibit & Poster Hall Hours

Location: Exhibit & Poster Hall 300 level (West)

8:30 AM – 9:10 AM MST

RFPT06--Biomarkers: Accelerating Inflammation & Infection Detection

Location: Theater B (Exhibit & Poster Hall)

Chair: – Emory University

Chair: – Arizona State University

IMI

8:30 AM – 9:10 AM MST

RFPT06.1- Diagnostic utility of plasma microbial cell-free DNA sequencing in people with cystic fibrosis

Location: Theater B (Exhibit & Poster Hall)

Speaker: – Boston Children's Hospital

8:30 AM – 9:10 AM MST

RFPT06.2- Early markers of chronic kidney disease in people with Cystic Fibrosis

Location: Theater B (Exhibit & Poster Hall)

Speaker: – Dartmouth College

8:30 AM – 9:10 AM MST

RFPT06.3- Evaluation of ivacaftor and antibiotic therapies on breath biomarkers for Pseudomonas aeruginosa and Staphylococcus aureus in cystic fibrosis

Location: Theater B (Exhibit & Poster Hall)

Speaker: – School of Biomedical Engineering, University of British Columbia

8:30 AM – 9:10 AM MST

RFPT06.4- Deep phenotyping of inflammatory proteins after elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis

Location: Theater B (Exhibit & Poster Hall)

Speaker: – Emory University

8:30 AM – 9:10 AM MST

RFPT06.5- Nasal nitric oxide increases in patients with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.

Location: Theater B (Exhibit & Poster Hall)

Speaker: – Chaité - Universitätsmedizin Berlin

8:30 AM – 9:10 AM MST

RFPT06.6- Inflammatory biomarkers to monitor CF lung disease in the era of CFTR modulators

Location: Theater B (Exhibit & Poster Hall)

Speaker: – Erasmus University Medical Center-Sophia Children's Hospital

8:30 AM – 9:10 AM MST

RFPT06.7- A multi-targeted approach to identify sputum and blood inflammatory cell responses to AR-501 as a measure of treatment response in subjects with cystic fibrosis

Location: Theater B (Exhibit & Poster Hall)

Speaker: – National Jewish Health

8:30 AM – 9:10 AM MST

RFPT06.8- Multiple exhaled breath condensate metabolites are associated with glucose intolerance and pulmonary function in children with cystic fibrosis

Location: Theater B (Exhibit & Poster Hall)

Speaker: – Emory University

8:30 AM – 9:10 AM MST

RFPT07--New & Upcoming Imaging Techniques in CF

Location: Theater A (Exhibit & Poster Hall)

Chair: – The University of North Carolina at Chapel Hill

Chair: – University of Alabama-Birmingham

CLIN

8:30 AM – 9:10 AM MST

RFPT07.1- Cystic fibrosis rat models demonstrate altered respiratory mechanics and X-ray velocimetry parameters

Location: Theater A (Exhibit & Poster Hall)

Speaker: – University of Adelaide / Women's and Children's Hospital

8:30 AM – 9:10 AM MST

RFPT07.2- Standardising European Imaging Practice: European Cystic Fibrosis Society – Clinical Trial Network Imaging Special Interest Groups

Location: Theater A (Exhibit & Poster Hall)

Speaker: – European Cystic Fibrosis Society Clinical Trial Network, Queens University Belfast

8:30 AM – 9:10 AM MST

RFPT07.3- Quantitative CT Analysis After Highly Effective Modulator Therapy

Location: Theater A (Exhibit & Poster Hall)

Speaker: – University of Iowa

8:30 AM – 9:10 AM MST

RFPT07.4- Long-Term Effects of Lumacaftor/Ivacaftor on Chronic Rhinosinusitis in Children with Cystic Fibrosis Detected with Magnetic Resonance Imaging

Location: Theater A (Exhibit & Poster Hall)

Speaker: – University Hospital Heidelberg

8:30 AM – 9:10 AM MST

RFPT07.5- Validation of a Novel Integrated Image Guided Potential Difference System to Facilitate Conduct of Lower Airway Potential Difference.

Location: Theater A (Exhibit & Poster Hall)

Speaker: – University of Alabama-Birmingham

8:30 AM – 10:30 AM MST

AM Coffee Break

9:15 AM – 9:45 AM MST

30 Minute Guided Meditation

Location: 230 North

9:30 AM – 11:00 AM MST

TPS04--Imaging & Clinical Outcome Measures

Location: Theater C (Exhibit & Poster Hall)

Chair: – University of Washington

Chair: – Cincinnati Children's Hospital

APPTT

9:30 AM – 11:00 AM MST

TPS04.1- Elexacaftor-Tezacaftor-Ivacaftor and spirometry-controlled chest CT scores in people with CF aged 6-11 years

Location: Theater C (Exhibit & Poster Hall)

Speaker:

9:30 AM – 11:00 AM MST

TPS04.2- Hyperpolarized 129Xe pulmonary magnetic resonance imaging and multiple breath washout to measure response to elexacaftor/tezacaftor/ivacaftor therapy in children

Location: Theater C (Exhibit & Poster Hall)

Speaker: – University of British Columbia

9:30 AM – 11:00 AM MST

TPS04.3- Elexacaftor/Tezacaftor/Ivacaftor Improves Bronchial Artery Dilatation Detected by Magnetic Resonance Imaging in Patients with Cystic Fibrosis

Location: Theater C (Exhibit & Poster Hall)

Speaker: – University Hospital Heidelberg

9:30 AM – 11:00 AM MST

TPS04.4- Interim Results of Test Reliability of 19F MRI in Mild CF Lung Disease

Location: Theater C (Exhibit & Poster Hall)

Speaker: – The University of North Carolina at Chapel Hill

9:30 AM – 11:00 AM MST

TPS04.5- Lung T1-MRI and Multi-Breath Washout detect longitudinal lung changes in children beginning elexacaftor/tezacaftor/ivacaftor (ETI) therapy.

Location: Theater C (Exhibit & Poster Hall)

Speaker: – University of Michigan

9:30 AM – 11:00 AM MST

TPS04.6- Longitudinal magnetic resonance imaging of morphological and perfusion abnormalities in patients with cystic fibrosis from infancy to end of adolescence

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Heidelberg University Hospital

9:30 AM – 11:00 AM MST

TPS04.7- Comprehension of early CF lung disease or how to TRACK-CF

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Germany

9:30 AM – 11:00 AM MST

TPS04.8- Oxygen Enhanced(OE)-MRI and Multiple breath washout with Short extension(MBWShX) are highly sensitive to Elexacaftor-Tezacaftor-Ivacaftor(ETI) initiation in a group with preserved pulmonary function

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Imperial College London

9:30 AM – 11:00 AM MST

TPS04.9- The Lung Clearance Index to Inform Clinical Decision-Making in Early CF Lung Disease: Findings from a Prospective Study

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Children's Health Ireland

9:30 AM – 11:00 AM MST

TPS04.10- Increasing the value of clinic visits for patients, families, and staff through annual lab pre-visit planning

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Kaiser Northwest Permanente

9:30 AM – 11:30 AM MST

W18--Novel Psychosocial Interventions

Location: 207 Lecture Hall (West)

Chair: – West Virginia University Medicine

Chair: – Boston Children's Hospital Pulmonary

SW/PSYCH

9:30 AM – 11:30 AM MST

W18.1- A virtual group intervention to promote physical and psychological wellness in children with CF: Courage to Be ME (through Movement and Empowerment)

Location: 207 Lecture Hall (West)

Speaker: – University of Colorado School of Medicine/Children's Hospital Colorado

9:30 AM – 11:30 AM MST

W18.2- A pilot feasibility trial to evaluate a tele-coaching intervention to improve self-management in adolescents and young adults with cystic fibrosis

Location: 207 Lecture Hall (West)

Speaker: – West Virginia University

9:30 AM – 11:30 AM MST

W18.3- The CF Wellness Program to treat fatigue: Pilot and feasibility study results

Location: 207 Lecture Hall (West)

Speaker: – Johns Hopkins University

9:30 AM – 11:30 AM MST

W18.4- Integrating CF-CBT into team-based care for adults with CF: Initiation of a randomized implementation trial in US and Canadian CF centers

Location: 207 Lecture Hall (West)

Speaker: – Massachusetts General Hospital/Harvard Medical School

9:30 AM – 11:30 AM MST

W18.5- Clinical Effort Against Smoke Exposure in Cystic Fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy

Location: 207 Lecture Hall (West)

Speaker: – University of Alabama at Birmingham

9:30 AM – 11:30 AM MST

W19--Population Based Research & Impact on Care

Location: 231 A-C (North)

Chair: – Dalhousie University

Chair: – University of California at Los Angeles

CLIN

9:30 AM – 11:30 AM MST

W19.1- Time between clinic visits among individuals with cystic fibrosis: Patterns across the lifespan

Location: 231 A-C (North)

Speaker: – MaineHealth & Northeastern University

9:30 AM – 11:30 AM MST

W19.2- Evaluating Precision Medicine Tools in Cystic Fibrosis (CF) for Racial and Ethnic Fairness

Location: 231 A-C (North)

Speaker: – Cincinnati Children's Hospital Medical Center

9:30 AM – 11:30 AM MST

W19.3- Cystic fibrosis-related infant and early-childhood mortality in a cohort from South India. This is just the tip of the iceberg!

Location: 231 A-C (North)

Speaker: – Christian Medical College and Hospital

9:30 AM – 11:30 AM MST

W19.4- Prevalence and Predictors of Increased Cardiovascular Risk in Adults with Cystic Fibrosis

Location: 231 A-C (North)

Speaker: – Johns Hopkins University School of Medicine

9:30 AM – 11:30 AM MST

W19.5- Environmental Exposures and Spatiotemporal Effects that Characterize Rapid Lung Function Decline in a Midwest U.S. Cystic Fibrosis Cohort

Location: 231 A-C (North)

Speaker: – Cincinnati Children's Hospital Medical Center

9:30 AM – 11:30 AM MST

W20--Microbial Ecology in CF

Location: 213 B (West)

Chair: – University of Alabama at Birmingham

Chair: – Children's Hospital of Philadelphia

IMI

9:30 AM – 11:30 AM MST

W20.1- Intracellular Pseudomonas aeruginosa in Cystic Fibrosis lung tissues

Location: 213 B (West)

Speaker: – McGill University

9:30 AM – 11:30 AM MST

W20.2- Sputum density of Aspergillus fumigatus markedly declines after treatment with elexacaftor/tezacaftor/ivacaftor

Location: 213 B (West)

Speaker: – University of Washington

9:30 AM – 11:30 AM MST

W20.3- Initiation of elexacaftor/tezacaftor/ivacaftor treatment lowers total bacterial load in the airways but does not increase microbial diversity or lead to eradication of known pathogens.

Location: 213 B (West)

Speaker: – Geisel School of Medicine at Dartmouth

9:30 AM – 11:30 AM MST

W20.4- Filamentous bacteriophage of Pseudomonas aeruginosa entangle cilia and impair mucociliary clearance in cystic fibrosis

Location: 213 B (West)

Speaker: – Children's Hospital of Los Angeles / University of Southern California

9:30 AM – 11:30 AM MST

W20.5- Antibiotics to treat common cystic fibrosis airway pathogens influence susceptibility to Mycobacterium abscessus lung infection

Location: 213 B (West)

Speaker: – National Jewish Health

9:30 AM – 11:30 AM MST

W21--In Vivo Models, Proof of Concept Trials, & Outcome Measures

Location: 103 AB (West)

Chair: – University of North Carolina at Chapel Hill Marsico Lung Institute

Chair: – University of Calgary

APPTT

9:30 AM – 11:30 AM MST

W21.1- Intestinal epithelial-specific Cftr knockout induces fecal dysbiosis and bowel inflammation in mice consuming anti-obstructive dietary regimens

Location: 103 AB (West)

Speaker: – University of Missouri

9:30 AM – 11:30 AM MST

W21.2- Infection/Inflammation Models in CF

Location: 103 AB (West)

Speaker: – University of Iowa

9:30 AM – 11:30 AM MST

W21.3- Factors associated with significantly corrected sweat chloride in people with CF taking Elexacaftor/Tezacaftor/Ivacaftor – Results from the PROMISE and RECOVER studies.

Location: 103 AB (West)

Speaker: – RCSI University of Medicine and Health Sciences

9:30 AM – 11:30 AM MST

W21.4- Ivacaftor ameliorates acute but not chronic Pseudomonas aeruginosa infection in CF rats

Location: 103 AB (West)

Speaker: – University of Alabama at Birmingham

9:30 AM – 11:30 AM MST

W21.5- Effect of acute systemic corticosteroids on clinical outcomes in cystic fibrosis pulmonary exacerbations.

Location: 103 AB (West)

Speaker: – University of Washington

9:30 AM – 11:30 AM MST

W22-What’s New in Clinical Trials in CF?

Location: 104 AB (West)

Chair: – University of British Columbia

Chair: – Columbia University Irving Medical Center

CLIN

9:30 AM – 11:30 AM MST

W22.1- Safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C- >T mutation to support Phase 1/2a clinical study

Location: 104 AB (West)

Speaker: – SpliSense Ltd., Jerusalem, Israel

9:30 AM – 11:30 AM MST

W22.2- Interim results of an open-label trial to evaluate ETI in individuals with cystic fibrosis and an N1303K mutation who are not eligible for modulator treatment

Location: 104 AB (West)

Speaker: – University of Alabama at Birmingham, Birmingham, AL USA

9:30 AM – 11:30 AM MST

W22.3- Response in imaging and lung function outcomes in the HyPOINT study

Location: 104 AB (West)

Speaker: – University of Toronto, Hospital for Sick Children

9:30 AM – 11:30 AM MST

W22.4- Maternal and fetal outcomes in the era of CFTR modulators (MAYFLOWERS) study: interim results.

Location: 104 AB (West)

Speaker: – University of Texas Southwestern Medical Center

9:30 AM – 11:30 AM MST

W22.5- A phase 1b/2a randomized, double-blind, placebo-controlled, multicenter study evaluating nebulized phage therapy in cystic fibrosis subjects with chronic Pseudomonas aeruginosa pulmonary infection

Location: 104 AB (West)

Speaker: – BiomX Inc

9:30 AM – 11:30 AM MST

W23--A to Zzzz's: Strategies for CF Sleep Disorders

Location: 106 A-C (West)

Chair: – University of Michigan / Michigan Medicine

Chair: – Nebraska Medicine

NRS

9:30 AM – 11:30 AM MST

W23.1- Updates on sleep disorders in CF

Location: 106 A-C (West)

Speaker: – University of Michigan / Michigan Medicine

9:30 AM – 11:30 AM MST

W23.2- Experience with sleep disorders

Location: 106 A-C (West)

Community Speaker: – Grand Island Public Schools

9:30 AM – 11:30 AM MST

W23.3- A Description of Sleep Breathing Disorder Prevalence, Risk Factors, and Treatment Among Adults with Cystic Fibrosis

Location: 106 A-C (West)

Speaker: – University of Toronto

9:30 AM – 11:30 AM MST

W23.4- Restless leg syndrome is highly prevalent in adults with cystic fibrosis and independently associated with poor sleep quality and poor glycemic control.

Location: 106 A-C (West)

Speaker: – University of Nebraska Medcal Center

9:30 AM – 11:30 AM MST

W23.5- Nocturnal pulse oximetry studies pre and post Elexacaftor/Tezacaftor/Ivacaftor: A retrospective review from a single cystic fibrosis center

Location: 106 A-C (West)

Speaker: – UH Rainbow Babies and Children's Hospital

9:30 AM – 11:30 AM MST

W24--Modulators & Nutrition

Location: 105 AB (West)

Chair: – Emory University School of Medicine

Chair: – University of Louisville

NTR

9:30 AM – 11:30 AM MST

W24.1- Impact of Elexacaftor/Tezacaftor/Ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE Peds GI

Location: 105 AB (West)

Speaker: – Pediatric Gastroenterology, Seattle Children's Hospital, Seattle, WA, USA

9:30 AM – 11:30 AM MST

W24.2- Pre-Modulator Microbiome Alterations Associated with Post-Modulator Growth Outcomes in Pediatric Cystic Fibrosis: Can we predict outcomes?

Location: 105 AB (West)

Speaker: – Dartmouth-Hitchcock Medical Center

9:30 AM – 11:30 AM MST

W24.3- Analysis of iron status after initiation of elexacaftor/tezacaftor/ivacaftor

Location: 105 AB (West)

Speaker: – University of Virginia

9:30 AM – 11:30 AM MST

W24.4- Analysis of fat-soluble vitamin levels after initiation of elexacaftor/tezacaftor/ivacaftor

Location: 105 AB (West)

Speaker: – University of Virginia

9:30 AM – 11:30 AM MST

W24.5- Alterations in the fecal microbiota in patients with advanced cystic fibrosis associated liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor

Location: 105 AB (West)

Speaker: – UCSF Benioff Children's Hospital

9:30 AM – 11:30 AM MST

W25--Best Abstracts in Endocrinology

Location: 101 A-C (West)

Chair: – University of Texas Health San Antonio

Chair: – Indiana University

CLIN

9:30 AM – 11:30 AM MST

W25.1- Personalized CFRD prediction model can reduce OGTT frequency in low-risk individuals without delaying CFRD diagnosis.

Location: 101 A-C (West)

Speaker: – Johns Hopkins University School of Medicine

9:30 AM – 11:30 AM MST

W25.2- Racial and ethnic differences in the development of cystic fibrosis related diabetes

Location: 101 A-C (West)

Speaker: – University of Texas Health San Antonio

9:30 AM – 11:30 AM MST

W25.3- Glycemia and insulin secretion before and two years after ETI

Location: 101 A-C (West)

Speaker: – University of Colorado

9:30 AM – 11:30 AM MST

W25.4- Lipid concentrations following 12-18 months of clinically-prescribed ETI

Location: 101 A-C (West)

Speaker: – Children's Hospital of Philadelphia

9:30 AM – 11:30 AM MST

W25.5- Longitudinal Changes in Bone Mineral Density in Adult Cystic Fibrosis Patients

Location: 101 A-C (West)

Speaker: – University of Toronto

9:30 AM – 11:30 AM MST

W26--What the Gut is Going On! GI Care From Top to BOTTOM

Location: 301 A (West)

Chair: – Massachusetts General Hospital

Chair: – Akron Children's Hospital

NRSNTRCLIN

9:30 AM – 11:30 AM MST

W26.1- Dietary intake and the gut microbiome in children with CF compared to their non-CF siblings

Location: 301 A (West)

Speaker: – UNMC/CHMC

9:30 AM – 11:30 AM MST

W26.2- Prevalence of acid blockade use and its association with social determinants of health amongst patients with cystic fibrosis: A preliminary analysis of Cystic Fibrosis Foundation registry data

Location: 301 A (West)

Speaker: – University of South Florida Morsani College of Medicine

9:30 AM – 11:30 AM MST

W26.3- Utilizing the TriNetX database to describe the prevalence of VTE and GI disease in pediatric Cystic Fibrosis

Location: 301 A (West)

Speaker: – Johns Hopkins All Children’s Hospital

9:30 AM – 11:30 AM MST

W26.4- Effect of low versus high dose pancreatic enzyme supplement on the body mass index in patients with cystic fibrosis.

Location: 301 A (West)

Speaker: – Rush Children`s Hospital

9:30 AM – 11:30 AM MST

W27--Exercise Updates

Location: 105 C (West)

Chair: – Georgia Prevention Institute

Chair: – Maine Medical Center

PT/RT

9:30 AM – 11:30 AM MST

W27.1- Mechanical airway clearance therapy, a treatment of the past?

Location: 105 C (West)

Speaker: – Thomas Jefferson University Hospital

9:30 AM – 11:30 AM MST

W27.2- Perception and participation in sport and exercise of people with cystic fibrosis in the era of highly effective modulator therapies (HEMT)

Location: 105 C (West)

Speaker: – Emory University

9:30 AM – 11:30 AM MST

W27.3- Performance of a breath-enhanced nebulizer after repeated cycles of thermal or chemical disinfection.

Location: 105 C (West)

Speaker: – University of Arkansas for Medical Sciences/Arkansas Children's Hospital

9:30 AM – 11:30 AM MST

W27.4- Remote exercise in cystic fibrosis patients: a pilot study using a wearable patch to measure sweat chloride

Location: 105 C (West)

Speaker: – Northwestern University

9:30 AM – 11:30 AM MST

W27.5- Impact of sustained exercise on cardiorespiratory fitness and lung function in adults with Cystic Fibrosis

Location: 105 C (West)

Speaker: – University of Kansas Medical Center

9:30 AM – 11:30 AM MST

W28--Innovations in CF Pharmacotherapy

Location: 102 AB (West)

Chair: – Banner Health

Chair: – Billings Clinic

PHARM

9:30 AM – 11:30 AM MST

W28.1- Evaluating mental health adverse event reports related to elexacaftor/tezacaftor/ivacaftor therapy in individuals with cystic fibrosis

Location: 102 AB (West)

Speaker: – University of Oklahoma School of Community Medicine

9:30 AM – 11:30 AM MST

W28.2- The impact of pharmacogenomic variation on elexcaftor/tezacaftor/ivacaftor concentrations in people with cystic fibrosis

Location: 102 AB (West)

Speaker: – UNC Medical Center

9:30 AM – 11:30 AM MST

W28.3- Evaluation of a pharmacy technician-based pre-clinic call program and its impact on medication adherence in cystic fibrosis patients

Location: 102 AB (West)

Speaker: – Valley Children's Healthcare

9:30 AM – 11:30 AM MST

W28.4- Outcomes of a pharmacist and pharmacy technician led methicillin-resistant staphylococcus aureus (MRSA) eradication program

Location: 102 AB (West)

Speaker: – St. Luke's Cystic Fibrosis Clinic

9:30 AM – 11:30 AM MST

W28.5- Evaluation of the drug-drug interaction potential of elexacaftor-rosuvastatin using a physiologically based pharmacokinetic simulation approach

Location: 102 AB (West)

Speaker: – University of Southern California Mann School of Pharmacy

9:30 AM – 11:30 AM MST

W29--Accelerating Progress Along the Path to a Cure

Location: 212 A-C (West)

Chair:

Chair: – University of Iowa

PTAC/CFTR

9:30 AM – 11:30 AM MST

W29.1- A CFTR super-exon strategy in W1282X intestinal organoids and mice

Location: 212 A-C (West)

Speaker: – CWRU

9:30 AM – 11:30 AM MST

W29.2- Anti-CD20 treatment prior to inhaled vector administration attenuates humoral and cellular immune responses and permits secondary gene transfer

Location: 212 A-C (West)

Speaker: – Tulane University

9:30 AM – 11:30 AM MST

W29.3- Pre-clinical development of an autologous stem cell gene therapy platform for treatment of cystic fibrosis sinus/upper airway disease

Location: 212 A-C (West)

Speaker: – Stanford University School of Medicine

9:30 AM – 11:30 AM MST

W29.4- Delivery of CFTR mRNA using polymeric nanoparticles in a cystic fibrosis mouse model

Location: 212 A-C (West)

Speaker: – Yale University

9:30 AM – 11:30 AM MST

W29.5- Nonsense suppressor tRNA picovectors represent a new therapeutic cargo for the treatment of PTC-associated Cystic Fibrosis

Location: 212 A-C (West)

Speaker: – University of Rochester Medical Center

11:30 AM – 2:00 PM MST

Lunch

11:40 AM – 12:40 PM MST

Poster Session: All Odd Numbered Posters

Location: Exhibit & Poster Hall

12:00 PM – 12:40 PM MST

FSC05--Conversation with Mary Lester

Location: Fireside Chat A (Exhibit & Poster Hall)

Speaker: – University of Southern California

Facilitator: – Augusta University Children's Hospital of Georgia

PT/RT

12:00 PM – 12:40 PM MST

FSC06--Conversation with Sara Brayshaw - Joy in Work

Location: Fireside Chat B (Exhibit & Poster Hall)

Speaker: – National Jewish Health

Facilitator: – Medical University of SC

NRS

12:00 PM – 1:30 PM MST

Adult Program Directors' Meeting

Location: Sheraton Hotel- Valley of the Sun AB

Affiliate Meeting

12:00 PM – 1:30 PM MST

Pediatric Program Directors' Meeting

Location: Sheraton Hotel- Valley of the Sun C

Affiliate Meeting

12:00 PM – 1:30 PM MST

U.S. Program Coordinators’ Meeting

Location: Sheraton - Phoenix Ballroom DE

Affiliate Meeting

12:40 PM – 1:40 PM MST

Poster Session: All Even Numbered Posters

Location: Exhibit & Poster Hall

12:50 PM – 1:30 PM MST

FSC07--Conversation with Kim Reno

Location: Fireside Chat A (Exhibit & Poster Hall)

Speaker: – CF Foundation

Facilitator: – Hartford Healthcare, Hartford, CT, USA

SW/PSYCH

12:50 PM – 1:30 PM MST

FSC08--Conversation with Terri Schindler

Location: Fireside Chat B (Exhibit & Poster Hall)

Speaker: – University Hospitals Rainbow and Babies Children's Hospital

Facilitator: – Washington University School of Medicine Adult Cystic Fibrosis Clinic

NTR

1:30 PM – 2:00 PM MST

30 Minute Guided Meditation

Location: 230 North

2:00 PM – 3:15 PM MST

PL2- "Micro-Management": The Changing Face of Infections in CF

Location: North Ballroom A-D

Speaker: – Pediatric Pulmonary, Seattle Children's Hospital, Seattle, WA, USA

Speaker: – Johns Hopkins University

3:30 PM – 5:00 PM MST

International CF Patient Registries Meeting

Location: Sheraton Hotel- Estrella

Affiliate Meeting

3:30 PM – 5:00 PM MST

TPS05--Nutrition Innovations

Location: Theater C (Exhibit & Poster Hall)

Chair: – University of Minnesota

Chair: – Stanford Children's Health

NTR

3:30 PM – 5:00 PM MST

TPS05.1- Nutritional Health in Pediatric Patients with Cystic Fibrosis: Weighing the Change Following Protocol Implementation

Location: Theater C (Exhibit & Poster Hall)

Speaker: – University of Kentucky College of Medicine

3:30 PM – 5:00 PM MST

TPS05.2- CF Teens Talk Project: A mixed methods evaluation of adherence to nutritional recommendations in adolescents with CF

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Alpert Medical School at Brown University

3:30 PM – 5:00 PM MST

TPS05.3- Reduction in abdominal symptoms measured by the CFAbd-Score over 6 months of treatment with Elexacaftor/Tezacaftor/Ivacaftor in children with CF aged 6-11– early results from the RECOVER study

Location: Theater C (Exhibit & Poster Hall)

Speaker: – RCSI University of Medicine and Health Sciences

3:30 PM – 5:00 PM MST

TPS05.4- Annual Screening for Liver Disease in Pediatric Patients

Location: Theater C (Exhibit & Poster Hall)

Speaker: – SUNY Upstate

3:30 PM – 5:00 PM MST

TPS05.5- Nutrition education kits for infants with cystic fibrosis

Location: Theater C (Exhibit & Poster Hall)

Speaker: – University of North Carolina Hospitals

3:30 PM – 5:00 PM MST

TPS05.6- Factors associated with nutrition risk for infants with CF less than two years of age

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Children's Mercy Hospital

3:30 PM – 5:00 PM MST

TPS05.7- Phase 1 Study of SNSP-003, A non-porcine pancreatic enzyme replacement therapy (PERT) using a novel endpoint

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Harvard Medical School

3:30 PM – 5:00 PM MST

TPS05.8- Assessment for sarcopenia shows decreased skeletal muscle mass and muscle quality in adults with cystic fibrosis

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Laney Graduate School

3:30 PM – 5:00 PM MST

TPS05.9- Development and Implementation of a Standardized Assessment Tool to Improve Nutritional Health of Adults with Cystic Fibrosis – A Quality Improvement Project

Location: Theater C (Exhibit & Poster Hall)

Speaker: – Dayton Children's Hospital

3:30 PM – 5:30 PM MST

S12--Best Practices in GI Care in the Post-Modulator Era

Location: 105 AB (West)

Chair: – Dartmouth-Hitchcock Medical Center

Chair: – UTSW/Children's Health

CLIN

3:30 PM – 5:30 PM MST

S12.1- Pancreatic Function on HEMT: Should we be adjusting enzymes?

Location: 105 AB (West)

Speaker: – University of Florida

3:30 PM – 5:30 PM MST

S12.2- Tube Feeding on HEMT: Rethinking placement and removal

Location: 105 AB (West)

Speaker: – University of Utah/Primary Children's Hospital

3:30 PM – 5:30 PM MST

S12.3- Liver Test Abnormalities: Beyond the Medication Label

Location: 105 AB (West)

Speaker: – Nationwide Children's Hospital/The Ohio State University

3:30 PM – 5:30 PM MST

S12.4- Constipation and Bloating on HEMT: Updates and Challenges

Location: 105 AB (West)

Speaker: – University of Washington

3:30 PM – 5:30 PM MST

S13--Updates in Spirometry/PFT Lab

Location: 213 B (West)

Chair: – IU Health

Chair: – The Hospital for Sick Children

PT/RT

3:30 PM – 5:30 PM MST

S13.1- Race and Precited Results in Spirometry

Location: 213 B (West)

Speaker: – UPMC Children's Hospital of Pittsburgh

3:30 PM – 5:30 PM MST

S13.2- The accuracy and feasibility of home spirometry as a clinical trial endpoint: The OUTREACH study

Location: 213 B (West)

Speaker: – University of Washington / Seattle Children's Research Institute

3:30 PM – 5:30 PM MST

S13.3- Using ATS/ERS guidelines to Improve Clinical Spirometry Data

Location: 213 B (West)

Speaker: – Children’s Hospital of Richmond at Virginia Commonwealth University

3:30 PM – 5:30 PM MST

S13.4- Novel techniques in measuring lung function and its clinical applications/implications

Location: 213 B (West)

Speaker: – Children's Health Ireland

3:30 PM – 5:30 PM MST

S14--Restoration of CFTR Ion Transport for All People With CF

Location: 102 AB (West)

Chair: – Washington University School of Medicine in St. Louis

Chair: – University of Iowa

PTAC/CFTR

3:30 PM – 5:30 PM MST

S14.1- Historical overview of genetic/molecular therapies for restoring CFTR function

Location: 102 AB (West)

Speaker: – University of Iowa Carver College of Medicine

3:30 PM – 5:30 PM MST

S14.2- Building the Path to the Cure: the role of AAV therapy

Location: 102 AB (West)

Speaker: – National Jewish Health

3:30 PM – 5:30 PM MST

S14.3- Application of splice switching ASOs for correction of CFTR mutations

Location: 102 AB (West)

Speaker: – Hebrew University

3:30 PM – 5:30 PM MST

S14.4- CM001, a clinical stage molecular prosthetic for CFTR that may benefit all people with CF

Location: 102 AB (West)

Speaker: – University of Illinois

3:30 PM – 5:30 PM MST

S15--Evolving Models of CF Care

Location: 207 Lecture Hall (West)

Chair: – University of Virginia

Chair: – Boston Children's Hospital

CLIN

3:30 PM – 5:30 PM MST

S15.1- Aging with CF and the role of lung transplant in the era of modulator therapy

Location: 207 Lecture Hall (West)

Speaker: – Univ. of Washington

3:30 PM – 5:30 PM MST

S15.2- Transforming care through artificial intelligence and machine learning

Location: 207 Lecture Hall (West)

Speaker: – Royal Papworth Hospital NHS Foundation Trust and Cambridge University

Speaker: – University of Cambridge

3:30 PM – 5:30 PM MST

S15.3- Role of remote monitoring technology for CF care

Location: 207 Lecture Hall (West)

Speaker: – Cystic Fibrosis Foundation

3:30 PM – 5:30 PM MST

S15.4- Patient perspective on the changing model of care

Location: 207 Lecture Hall (West)

Community Speaker: – University of Nebraska Adult Cystic Fibrosis Program

3:30 PM – 5:30 PM MST

S16--Decoding Complex CF Care: Simplify Dosing, Conquer Interactions, Mitigate Adverse Effects & Unleash Theratyping

Location: 212 A-C (West)

Chair: – Children's Mercy Kansas City

Chair: – Concordia University of Wisconsin School of Pharmacy/Froedtert Health

PHARM

3:30 PM – 5:30 PM MST

S16.1- Murky or Marvelous? Making Dose Modifications to CFTR Modulators

Location: 212 A-C (West)

Speaker: – Virginia Commonwealth University

3:30 PM – 5:30 PM MST

S16.2- Are we there yet? Factors to consider and guide CF regimen modification for patients on highly effective modulator therapy

Location: 212 A-C (West)

Speaker: – Nationwide Children's Hospital

3:30 PM – 5:30 PM MST

S16.3- Advancing personalized medicine: concepts and updates on theratyping

Location: 212 A-C (West)

Speaker: – University of Alabama at Birmingham, Birmingham, AL USA

3:30 PM – 5:30 PM MST

S16.4- A patient experience with theratyping

Location: 212 A-C (West)

Community Speaker: – Blood & Medical Device Industries

3:30 PM – 5:30 PM MST

S17--CFTR Structure, Function, & Cellular Biology

Location: 103 AB (West)

Chair: – McGill University

Chair: – BioISI – Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Lisboa Portugal

PTAC/CFTR

3:30 PM – 5:30 PM MST

S17.1- Cryo-EM studies of human CFTR unfolding

Location: 103 AB (West)

Speaker: – Columbia Iniversity

3:30 PM – 5:30 PM MST

S17.2- Molecular mechanism of CFTR channel regulation by protein kinase A

Location: 103 AB (West)

Speaker: – Semmelweis University Department of Biochemistry

3:30 PM – 5:30 PM MST

S17.3- Utilizing ribosome-directed small molecules and nucleotide-based approaches to overcome distinct subclasses of CFTR variants

Location: 103 AB (West)

Speaker: – Emory University School of Medicine

3:30 PM – 5:30 PM MST

S17.4- Findings from the CF Genome Project that inform CF pathophysiology

Location: 103 AB (West)

Speaker: – Johns Hopkins University

3:30 PM – 5:30 PM MST

S18--Pregnancy & Fertility

Location: 301 C (West)

Chair: – Oregon Health and Science University

Chair: – University of Alabama at Birmingham School of Nursing

CLIN

3:30 PM – 5:30 PM MST

S18.1- Female Fertility and Infertility in CF

Location: 301 C (West)

Speaker: – University of Pennsylvania Perelman School of Medicine

3:30 PM – 5:30 PM MST

S18.2- Newest updates on pregnancy in people with CF

Location: 301 C (West)

Speaker: – University of Texas Southwestern Medical Center

3:30 PM – 5:30 PM MST

S18.3- Taking care of infants who were exposed to CFTR modulators in utero

Location: 301 C (West)

Speaker: – SUNY Upstate Medical University

3:30 PM – 5:30 PM MST

S18.4- Family Planning in the Modern Era of Cystic Fibrosis

Location: 301 C (West)

Speaker: – University of Pittsburgh

3:30 PM – 5:30 PM MST

S19--Let’s Be Blunt: Cannabis Use in CF

Location: 301 A (West)

Chair: – Phoenix Children's Hospital

Chair: – Doernbecher Children's Hospital

NRS

3:30 PM – 5:30 PM MST

S19.1- Existing Research on THC

Location: 301 A (West)

Speaker: – University of Michigan / Michigan Medicine

3:30 PM – 5:30 PM MST

S19.2- Existing Research on CBD

Location: 301 A (West)

Speaker: – University of Louisville Health

3:30 PM – 5:30 PM MST

S19.3- GI effects of THC/CBD

Location: 301 A (West)

Speaker: – Central Florida Pulmonary Group

3:30 PM – 5:30 PM MST

S19.4- Usage Trends and Perceptions

Location: 301 A (West)

Speaker: – St. Paul's Hospital

3:30 PM – 5:30 PM MST

S20--Impact of Polymicrobial Interactions on Antimicrobial Resistance & Virulence in CF

Location: 104 AB (West)

Chair: – University of Münster

Chair: – Children’s National Hospital

IMI

3:30 PM – 5:30 PM MST

S20.1- Treatment of co-infections in pulmonary exacerbations

Location: 104 AB (West)

Speaker: – Seattle Children's Hospital/University of Washington

3:30 PM – 5:30 PM MST

S20.2- Modeling polymicrobial communities/antimicrobial resistance

Location: 104 AB (West)

Speaker: – Geisel School of Medicine at Dartmouth

3:30 PM – 5:30 PM MST

S20.3- SA/PA interactions

Location: 104 AB (West)

Speaker: – CIRI - Université Lyon1- France

3:30 PM – 5:30 PM MST

S20.4- Immune modulation by resident flora including anaerobes

Location: 104 AB (West)

Speaker: – Ghent University

3:30 PM – 5:30 PM MST

S21--What in the ‘Omics?

Location: 231 A-C (North)

Chair: – University of Toronto and The Hospital for Sick Children

Chair: – Department of Pediatrics, Emory University

APPTT

3:30 PM – 5:30 PM MST

S21.1- Big data: Analyzing ‘omics research datasets and planning for limitations of trial design

Location: 231 A-C (North)

Speaker: – Telethon Kids Institute

3:30 PM – 5:30 PM MST

S21.2- Multi-'omic approaches to discern complex phenotypes in cystic fibrosis

Location: 231 A-C (North)

Speaker: – Emory University

3:30 PM – 5:30 PM MST

S21.3- Human GWAS in CF and COPD: Moving from candidate genes to mechanism

Location: 231 A-C (North)

Speaker: – University of North Carolina at Chapel Hill

3:30 PM – 5:30 PM MST

S21.4- Omics profiling: Predicting and monitoring treatment responses

Location: 231 A-C (North)

Speaker: – Geisel School of Medicine at Dartmouth

3:30 PM – 5:30 PM MST

S22--Let’s Focus on ADHD & Executive Functioning

Location: 106 A-C (West)

Chair: – Stanford University School of Medicine

Chair: – Nationwide Children's Hospital

SW/PSYCH

3:30 PM – 5:30 PM MST

S22.1- Neuropsychological Implications Across the Lifespan for People with CF and ADHD

Location: 106 A-C (West)

Speaker: – Medical University of South Carolina

3:30 PM – 5:30 PM MST

S22.2- CF, ADHD, or Just Regular Kid Stuff?: ADHD in Pediatric Patients with Cystic Fibrosis

Location: 106 A-C (West)

Speaker: – University of Virginia

3:30 PM – 5:30 PM MST

S22.3- All about the Medication and Cognition in Adult People with CF

Location: 106 A-C (West)

Speaker: – Stanford University School of Medicine

3:30 PM – 5:30 PM MST

S22.4- Sleep Disturbances in People with Cystic Fibrosis - A Potential Risk Factor for ADHD?

Location: 106 A-C (West)

Speaker: – UT Southwestern Medical Center

5:45 PM – 6:45 PM MST

Junior Investigators Best Abstract in Basic Science

Location: 125 AB (North)

Chair: – National Jewish Health

Chair: – Emory University School of Medicine

Panelist:

Panelist: – Yale University School of Medicine

Panelist:

Panelist: – CWRU

Panelist: – Emory University School of Medicine

Panelist:

Panelist: – University of North Carolina

5:45 PM – 6:45 PM MST

Junior Investigators Best Abstract in Clinical Research

Location: 225 AB (North)

Chair: – Massachusetts General Hospital/Harvard Medical School

Chair: – Indiana University School of Medicine

Panelist: – University of Pennsylvania

Panelist: – Behavioral Health Systems Research, Miami, FL, USA

Panelist: – University of Texas Southwestern Medical Center

Panelist: – University of Washington

Panelist:

5:45 PM – 7:00 PM MST

New Program Directors' Reception

Location: Renaissance Hotel- Salon 3-4

Affiliate Meeting

6:00 PM – 7:00 PM MST

Reception for International CF Clinicians and Organizations

Location: Renaissance Hotel- Salon 1-2

Affiliate Meeting

6:00 PM – 8:00 PM MST

RC Reception

Location: Renaissance Hotel- Salon 5-8

Affiliate Meeting

7:00 PM – 8:30 PM MST

Speakers & Fellows Reception

Location: Renaissance Hotel- Skyline Terrace, 5th Floor

8:00 PM – 10:30 PM MST

Emily's Entourage Reception

Location: Sheraton Hotel- Deer Valley

Affiliate Meeting